CLOSEOUT LETTER
Langlinais’ Baking Company MARCS-CMS 625493 —
- Delivery Method:
- Via Email
- Product:
- Food & Beverages
- Recipient:
-
Recipient NameRobbie Langlinais
-
Recipient TitlePresident/CEO
- Langlinais’ Baking Company
814 West Congress St.
Lafayette, LA 70501
United States-
- robbie@langlinaisbakery.com
- Issuing Office:
- Office of Human and Animal Foods Operations-East
United States
Dear Mr. Langlinais:
The Food and Drug Administration has completed evaluation of your corrective actions in response to our Warning Letter 625493, dated March14, 2022. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Christopher N. Dedeaux
Compliance Officer
Office of Human and Animal Foods Operations
Division 5 East